Condition: Lung Cancer (NSCLC) · Leptomeningeal Metastasis · Sponsor: Shanghai Chest Hospital
This is a prospective, single-arm, phase Ia clinical study, which was designed to evaluate the efficacy and safety of Pemetrexed Combined With Bevacizumab Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC.
This description comes directly from the study's public registry record.
Hua Zhong, MD · +86 021-22200000 · eddiedong8@hotmail.com
Always discuss trial participation with your own doctor first.
| Shanghai Chest Hospital | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06663306